Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.100 +0.030 (+1.45%)

Delayed Quote Updated: 1:37 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aytu BioPharma, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Aytu BioPharma Announces Publication of Data Demonstrating Ultraviolet-A Light Reduces Cellular Cytokine Release from Human Endotracheal Cells Infected with Coronavirus

July 27, 2021

ENGLEWOOD, CO / ACCESSWIRE / July 27, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products,...

From Aytu BioPharma, Inc.

Via AccessWire

Topics Regulatory Compliance

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 21, 2021

Gainers Chembio Diagnostics (NASDAQ: CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million....

Via Benzinga

Aytu BioPharma Announces Peer-Reviewed Publication of Clinical Results from Healight(TM) Pilot Study

June 28, 2021

Results Indicate That Endotracheal UVA Light Catheter Therapy is Associated with Significant Reduction in SARS-CoV-2 Viral Load and Improvement in Clinical Outcomes in Mechanically Ventilated COVID-19...

From Aytu BioPharma, Inc.

Via AccessWire

Topics Regulatory Compliance

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO ↗

July 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 22, 2021

Gainers Anavex Life Sciences (NASDAQ:AVXL) stock increased by 17.07% to $25.92 during Tuesday's regular session. As of 12:33 EST, this security is trading at a volume...

Via Benzinga

48 Biggest Movers From Yesterday ↗

June 22, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,...

Via Benzinga

Technical Levels To Watch In Aytu BioPharma Stock ↗

June 21, 2021

Aytu BioPharma Inc. (NASDAQ: AYTU) shares were rallying Monday after retail traders were able to push the stock higher. The stock has traded on above-average volume with...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 21, 2021

Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a...

Via Benzinga

31 Stocks Moving In Monday's Mid-Day Session ↗

June 21, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)...

Via Benzinga

21 Stocks Moving in Monday's Pre-Market Session ↗

June 21, 2021

Gainers Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V (NYSE: CNHI) announced plans to acquire Raven Industries for $58 per...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

June 11, 2021

Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 37.5% to $27.50...

Via Benzinga

What's Next For Aytu BioPharma Stock As It Gaps Up To Resistance? ↗

June 08, 2021

Aytu BioPharma Inc. (NASDAQ: AYTU) shares saw a gap up Tuesday morning as retail traders tried to push the stock higher. The stock saw a sizable premarket move and opened at $6.15...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 08, 2021

Gainers Aytu BioPharma (NASDAQ:AYTU) stock increased by 19.36% to $6.41 during Tuesday's pre-market session. The market value of their outstanding shares is at $161.3...

Via Benzinga

28 Stocks Moving in Tuesday's Pre-Market Session ↗

June 08, 2021

Gainers Aytu Biopharma, Inc. (NASDAQ: AYTU) rose 37.8% to $7.40 in pre-market trading. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) rose 23.5% to $3.89 in pre-market trading...

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

June 08, 2021

Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares jumped 72.4% to $20.55 amid increased retail investor interest in the stock. NextDecade Corporation (NASDAQ: NEXT...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

Aytu BioPharma to Present at Upcoming June Investor Conferences

May 25, 2021

ENGLEWOOD, CO / ACCESSWIRE / May 25, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products,...

From Aytu BioPharma, Inc.

Via AccessWire

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO ↗

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

30 Stocks Moving in Tuesday's Pre-Market Session ↗

May 18, 2021

Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 37.8% to $1.64 in pre-market trading after the company said it will receive $30 million in added payments during...

Via Benzinga

Recap: Aytu BioPharma Q3 Earnings ↗

May 17, 2021

Shares of Aytu BioPharma (NASDAQ:AYTU) decreased in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 186.67% year over year to...

Via Benzinga

Aytu BioPharma Reports Fiscal Third Quarter 2021 Financial Results and Recent Business Highlights

May 17, 2021

- Closed merger with Neos Therapeutics creating a proforma combined $100 million revenue specialty pharmaceutical company - - Added late-stage pediatric onset rare disease asset, protein kinase C β...

From Aytu BioPharma, Inc.

Via AccessWire

Topics Regulatory Compliance

Earnings Scheduled For May 17, 2021 ↗

May 17, 2021

Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off ↗

May 15, 2021

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the...

Via Benzinga

Aytu BioPharma Announces Publication of In Vitro Study Demonstrating That Ultraviolet-A Light Increases Mitochondrial Anti-Viral Signaling Protein Within Cells

May 12, 2021

ENGLEWOOD, CO / ACCESSWIRE / May 12, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products,...

From Aytu BioPharma, Inc.

Via AccessWire

Topics Regulatory Compliance

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.